Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis
Purpose: Solid organ transplant recipients (SOTR) have a high risk for severe COVID-19
infection; hence it is necessary to find alternative treatment strategies to protect these …
infection; hence it is necessary to find alternative treatment strategies to protect these …
[HTML][HTML] Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
V López, A Mazuecos, F Villanego… - Nefrología (English …, 2023 - Elsevier
Abstract SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant
activity in our country. Mortality and the risk of complications associated with COVID-19 in …
activity in our country. Mortality and the risk of complications associated with COVID-19 in …
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European …
M Hilhorst, FJ Bemelman, A Bruchfeld… - Nephrology Dialysis …, 2023 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic led to rapid
vaccine development and large global vaccination schemes. However, patients with …
vaccine development and large global vaccination schemes. However, patients with …
Clinical practice guideline–supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre
K Hammond, F Bourdeau, M Klein… - Journal of the …, 2024 - utppublishing.com
Background: Immunocompromised patients remain at risk of progression to severe COVID-
19 disease. Methods: We describe clinical COVID-19-related outcomes after administration …
19 disease. Methods: We describe clinical COVID-19-related outcomes after administration …
[HTML][HTML] Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
FJ Candel, M Salavert, DL Mingot… - Revista Española de …, 2023 - ncbi.nlm.nih.gov
Recipients of solid organ transplants (SOT) are at higher risk of infection by SARS-CoV-2
virus especially due to chronic immunosuppression therapy and frequent multiple comorbid …
virus especially due to chronic immunosuppression therapy and frequent multiple comorbid …
[HTML][HTML] Actualización de las recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal
V López, A Mazuecos, F Villanego, M López-Oliva… - nefrologia, 2023 - Elsevier
La infección por el SARS-CoV-2 (COVID-19) ha supuesto un importante impacto en la
actividad trasplantadora en nuestro país. Era esperable que la mortalidad y el riesgo de …
actividad trasplantadora en nuestro país. Era esperable que la mortalidad y el riesgo de …
What Is New in Prophylaxis and Treatment of COVID-19 in Renal Transplant Patients? A Report from an ESOT Meeting on the Topic
M Salvadori - Transplantology, 2022 - mdpi.com
I should highlight that this manuscript is not a formal review on the topic, but a report from an
ESOT meeting held on 22 June 2022. The assumption of immunosuppressants exposes …
ESOT meeting held on 22 June 2022. The assumption of immunosuppressants exposes …
Pregnant Women's Performance toward the COVID-19 Pandemic in El-Minia City
GM Abdelazim, EAEL Emam… - Minia Scientific Nursing …, 2023 - journals.ekb.eg
Background: Pregnancy-related changes in physiology, mechanics, and immunology may
have an impact on the susceptibility to as well as severity of COVID-19. Moreover to the …
have an impact on the susceptibility to as well as severity of COVID-19. Moreover to the …
What is New in Prophylaxis and Treatment of Covid-19 in Renal Transplant Patients?
M Salvadori - 2022 - preprints.org
Kidney transplant recipients, because of a weak immune response due to the assumption of
immunosuppressant are exposed to the risk of COVID-19 infection. This fact realize the …
immunosuppressant are exposed to the risk of COVID-19 infection. This fact realize the …
[PDF][PDF] Sotrovimab: una opción terapéutica en trasplante pulmonar Sotrovimab: a therapeutic option in lung transplant patients
R Gutiérrez-Larraya-Sánchez-Andrade… - Edad media - scholar.archive.org
Antecedentes: Los trasplantados pulmonares son un grupo con mayor riesgo de desarrollar
enfermedad por coronavirus 2019 (COVID-19) grave. El sotrovimab demostró reducir el …
enfermedad por coronavirus 2019 (COVID-19) grave. El sotrovimab demostró reducir el …